Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss

被引：19

作者：

Settin, Ahmad ^{[1
]}

Alkasem, RababAbo ^{[1
]}

Ali, Ehab ^{[2
]}

Elbaz, Rizk ^{[1
]}

Mashaley, Abdel Megid ^{[3
]}

机构：

[1] Mansoura Univ, Genet Unit, Children Hosp, Mansoura, Egypt

[2] Tanta Univ, Dept Biochem, Fac Sci, Tanta, Egypt

[3] Mansoura Univ, Dept Obstet & Gynecol, Fac Med, Mansoura, Egypt

来源：

HEMATOLOGY | 2011年 / 16卷 / 01期

关键词：

Recurrent pregnancy loss; Thrombophilia; Factor V Leiden; Prothrombin; FETAL LOSS; G20210A MUTATIONS; WOMEN; THROMBOPHILIA; COAGULATION; POLYMORPHISMS; METAANALYSIS; ASSOCIATION; MISCARRIAGE; PREVALENCE;

D O I：

10.1179/102453311X12902908411959

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Thrombophilias have been suggested as a possible cause of recurrent pregnancy loss (RPL). Objective: Testing for the association of factor V Leiden (FVL) and prothrombin (FII) mutations with RPL among cases from the Nile Delta region of Egypt. Subjects and methods: Participants included 72 cases having a history of two or more events of unexplained RPL and 70 controls with a good obstetric history. Detection of FVL (G1691A) and FII (G20210A) mutations was carried out using PCR with sequence specific primers. Results: Cases showed a significantly higher frequency of FVL GA (OR=21.38, P<0.0001) and FII GA (OR=36.7, P<0.0001) genotypes. Cases with two or more risk factors had significant higher frequency of both mutant genotypes, while no significant difference could be elicited related to primary or secondary infertility, number of fetal losses, or phase of pregnancy loss. Conclusion: Screening for thrombophilic mutations may help in the prevention of unexplained RPL.

引用

页码：59 / 63

页数：5

共 32 条

[1] Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey [J].

Altintas, Abdullah ;

Pasa, Semir ;

Akdeniz, Nurten ;

Cil, Timucin ;

Yurt, Murat ;

Ayyildiz, Orhan ;

Batun, Sabri ;

Isi, Hilmi .

ANNALS OF HEMATOLOGY, 2007, 86 (10) :727-731

[2]

BELINDA C, 2005, OBSTET GYNACOL, V17, P591

[3]

Brenner B, 1999, THROMB HAEMOSTASIS, V82, P6

[4] Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss [J].

Carp, H ;

Salomon, O ;

Seidman, D ;

Dardik, R ;

Rosenberg, N ;

Inbal, A .

HUMAN REPRODUCTION, 2002, 17 (06) :1633-1637

[5] Procoagulant and anticoagulant properties of coagulation factor V:: Factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms [J].

Dahlbäck, B .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 133 (05) :415-422

[6] Blood coagulation and its regulation by anticoagulant pathways:: genetic pathogenesis of bleeding and thrombotic diseases [J].

Dahlbäck, B .

JOURNAL OF INTERNAL MEDICINE, 2005, 257 (03) :209-223

[7] Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages [J].

Foka, ZJ ;

Lambropoulos, AF ;

Saravelos, H ;

Karas, GB ;

Karavida, A ;

Agorastos, T ;

Zournatzi, V ;

Makris, PE ;

Bontis, J ;

Kotsis, A .

HUMAN REPRODUCTION, 2000, 15 (02) :458-462

[8] Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. [J].

Gerhardt, A ;

Scharf, RE ;

Beckmann, MW ;

Struve, S ;

Bender, HG ;

Pillny, M ;

Sandmann, W ;

Zotz, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :374-380

[9]

Grandone E, 1997, THROMB HAEMOSTASIS, V77, P822

[10]

Hézard N, 1998, THROMB HAEMOSTASIS, V79, P1054

← 1 2 3 4 →